Judith Flore Tchuissang Mbougnia

Dr. Judith Flore Tchuissang Mbougnia

Department of Organic Chemistry, University of Yaounde I, Yaounde, Cameroon, Yaoundé, Centre, Cameroon
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Biochemical Systematics and Ecology
Verified
Journal Article
Closed access
Judith Flore Tchuissang MbougniaJudith Flore Tchuissang Mbougnia
Judith Flore Tchuissang Mbougnia
GHGervais M. Happi
Gervais M. Happi
GBGabin Bitchagno
Gabin Bitchagno
MAMaurice Ducret Awouafack
Maurice Ducret Awouafack
BLBruno N. Lenta
Bruno N. Lenta
MTMathieu Tene
Mathieu Tene

18 November 2020 in Natural Product Research
Verified
Journal Article
Closed access
Judith Flore Tchuissang MbougniaJudith Flore Tchuissang Mbougnia
Judith Flore Tchuissang Mbougnia
GBGabin Bitchagno
Gabin Bitchagno
SWSteven Collins N. Wouamba
Steven Collins N. Wouamba
JJJean-Bosco Jouda
Jean-Bosco Jouda
MAMaurice Ducret Awouafack
Maurice Ducret Awouafack
NSNorbert Sewald
Norbert Sewald
Two new fatty acid esters of triterpenoids (1–2) together with eleven known compounds (3–13) were obtained after investigation of the CH2Cl2-MeOH (1:1) crude extract from the leaves of Schefflera barteri Harms. All these compounds (1–13) were isolated for the first time from this plant among which compounds 3, 4, 6 and 9–13 were also isolated from the genus Schefflera for the first time. The structures of the isolated compounds were elucidated by analyses of their spectroscopic data (1D and 2D NMR, and MS). The antibacterial and cytotoxic activities of crude extracts, fractions and compounds (1, 2, 5, 6, 8 and 9) were investigated against both Gram-negative and Gram-positive bacteria strains as well as on human cervix carcinoma and colon adenocarcinoma cancer cell lines, respectively. They showed weak to significant activity towards the strains and malignant cells used. Graphical Abstract

26 August 2021 in Advances in Traditional Medicine
Verified
Journal Article
Closed access
PDF file
ODOlive M. F. Demgne
Olive M. F. Demgne
Judith Flore Tchuissang MbougniaJudith Flore Tchuissang Mbougnia
Judith Flore Tchuissang Mbougnia
ASArmel SEUKEP
Armel SEUKEP
MAMBAVENG T Armelle
MBAVENG T Armelle
MTMathieu Tene
Mathieu Tene
KKKuete Kuete
Kuete Kuete

17 November 2023 in Natural Product Research
Verified
Journal Article
Closed access
LMLarissa M. Magnibou
Larissa M. Magnibou
SWSteven C. N. Wouamba
Steven C. N. Wouamba
AYAbel J. G. Yaya
Abel J. G. Yaya
Judith Flore Tchuissang MbougniaJudith Flore Tchuissang Mbougnia
Judith Flore Tchuissang Mbougnia
GNGuy S. S. Njateng
Guy S. S. Njateng
TETalla Emmanuel
Talla Emmanuel
A rapid untargeted UHPLC-Q-TOF-ESI-MS/MS-Based metabolomic profiling of the medicinal plant Entada abyssinica was performed. A total of 18 metabolites were detected, of which 10 could not be identified. Based on this result, an extensive chemical investigation of the CH2Cl2-MeOH (1:1) extract of this plant was carried out, leading to the isolation of a new ceramide, named entadamide (1), together with nine known compounds: monomethyl kolavate (2), 24-hydroxytormentic acid (3) chondrillasterol (4), 3-O-beta-D glucopyranosylstigmasterol (5), 3-O-beta-D glucopyranosylsitosterol (6), quercetin 3 '-methylether (7), 2,3-dihydroxypropyl icosanoate (8), 2,3-dihydroxy-propyl 23-hydroxytricosanoate (9) and 2,3-dihydroxy-propyl 24-hydroxytetracosanoate (10). Their structures were elucidated by the analyses of their spectroscopic and spectrometric data (1D and 2D NMR, and HRESI-MS) in comparison with those reported in the literature. Furthermore, the crude extract and some isolated compounds were tested against non-ciprofloxacin resistant strains viz, Pseudomonas aeruginosa (ATCC 27853), Escherichia coli (ATCC 25922), Samonella thyphi (ATCC 19430) and Samonella enterica (NR4294). The tested samples demonstrated significant activity against all the tested bacteria (MIC values: 3.12-12.5 mu g/mL). [Graphical Abstract]

20 May 2021
Verified
Journal Article
Closed access
LMLarissa Mekontso Magnibou
Larissa Mekontso Magnibou
Jean Noël NyembJean Noël Nyemb
Jean Noël Nyemb
CMCyrille Yollande Fomogne-Fodjo Magne
Cyrille Yollande Fomogne-Fodjo Magne
Judith Flore Tchuissang MbougniaJudith Flore Tchuissang Mbougnia
Judith Flore Tchuissang Mbougnia
BLBosco Peron Leutcha
Bosco Peron Leutcha
ETEmmanuel Talla
Emmanuel Talla

23 July 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Judith Flore Tchuissang MbougniaJudith Flore Tchuissang Mbougnia
Judith Flore Tchuissang Mbougnia
BOSCO PERON LEUTCHABOSCO PERON LEUTCHA
BOSCO PERON LEUTCHA
GHGervais Mouthé Happi
Gervais Mouthé Happi
OAOluwasegun Adekanmi Adedokun
Oluwasegun Adekanmi Adedokun
MTMathieu Tene
Mathieu Tene
ENEpole Ngolle Ntungwe
Epole Ngolle Ntungwe
Background: Triple-Negative Breast Cancer (TNBC) remains the most aggressive oncological challenge within the African continent, characterized by high molecular heterogeneity, early onset in African women, and the absence of hormonal receptors. Multi-drug resistance (MDR), driven by ATP-binding cassette (ABC) efflux pumps and supported by the persistence of cancer stem cells (CSCs) within the tumor microenvironment, significantly compromises clinical outcomes and traditional treatment efficacy. Objective: This systematic review evaluates the ethnobotanical relevance, phytochemical diversity, and toxicity of some medicinal plants from the African pharmacopoeia specifically utilized or investigated for their activity against the TNBC phenotype. Methods: Following PRISMA guidelines, a systematic search was executed across PubMed, ScienceDirect, Scopus, Web of Science, and AJOL. The study focuses on original research published between 2011 and 2026 utilizing TNBC-specific models (such as MDA-MB-231, BT-20, HCC1937, or 4T1) and analyses the growth habits, parts used, and traditional administration modes of the selected African plant species, distributed across Western, Central, Southern, and Eastern Africa. Following a rigorous multi-reviewer screening process, a final set of 52 primary articles representing 30 distinct genera and 22 botanical families was selected for qualitative and quantitative synthesis. Results: This review identifies plant species actively used or studied in Africa for their anti-TNBC potential, with the most representative botanical families being Asteraceae (13%), Fabaceae (7%), and Annonaceae (7%). These species are traditionally administered through various methods, including decoction, infusion, and mastication, utilizing diverse plant parts such as leaves, stem and root barks. Significant cytotoxic activities against TNBC cell lines (notably MDA-MB-231) were recorded, with IC50 values as low as 5.10 ± 0.28 µg/mL for Catharanthus roseus and 13.56 µg/mL for Nauclea pobeguinii. Furthermore, species such as Vernonia amygdalina and Curcuma longa demonstrated a capacity to enhance the effectiveness of conventional chemotherapy like Doxorubicin, suggesting a strong potential for chemosensitization and therapeutic synergy in managing resistant breast cancer phenotypes. Conclusions: Standardized African phytomedicines represent a promising frontier in overcoming TNBC chemoresistance. However, the lack of clinical trials and end-to-end drug development infrastructure on the continent remains a significant barrier. Transitioning to nano-formulated delivery systems and establishing regional drug discovery hubs under the ethical framework of the Nagoya Protocol are essential steps toward developing precise and equitable oncology treatments from Africa’s rich biodiversity.